DK0527760T3 - Fremgangsmåder og præparater til vaccination mod HIV - Google Patents
Fremgangsmåder og præparater til vaccination mod HIVInfo
- Publication number
- DK0527760T3 DK0527760T3 DK91907077.1T DK91907077T DK0527760T3 DK 0527760 T3 DK0527760 T3 DK 0527760T3 DK 91907077 T DK91907077 T DK 91907077T DK 0527760 T3 DK0527760 T3 DK 0527760T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- preparations
- against hiv
- vaccination against
- env
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title 1
- 238000002255 vaccination Methods 0.000 title 1
- 102100034353 Integrase Human genes 0.000 abstract 3
- 108010078428 env Gene Products Proteins 0.000 abstract 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- AIDS & HIV (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50478590A | 1990-04-03 | 1990-04-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0527760T3 true DK0527760T3 (da) | 1995-11-27 |
Family
ID=24007729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91907077.1T DK0527760T3 (da) | 1990-04-03 | 1991-04-01 | Fremgangsmåder og præparater til vaccination mod HIV |
Country Status (10)
Country | Link |
---|---|
US (2) | US5674984A (da) |
EP (1) | EP0527760B1 (da) |
JP (1) | JP3494300B2 (da) |
AT (1) | ATE125157T1 (da) |
AU (2) | AU647108B2 (da) |
CA (1) | CA2078546A1 (da) |
DE (1) | DE69111440T2 (da) |
DK (1) | DK0527760T3 (da) |
NZ (1) | NZ237666A (da) |
WO (1) | WO1991015238A1 (da) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5614612A (en) * | 1990-03-09 | 1997-03-25 | Haigwood; Nancy L. | Purified gp120 compositions retaining natural conformation |
HUT66445A (en) * | 1990-10-26 | 1994-11-28 | New York Health Res Inst | Monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
FR2676071B1 (fr) * | 1991-05-02 | 1994-11-18 | Transgene Sa | Nouveau variant gp160 non-clivable, soluble, de forme hybride. |
AU700371B2 (en) | 1993-06-07 | 1999-01-07 | Genentech Inc. | Hiv envelope polypeptides |
US6913767B1 (en) | 1993-10-25 | 2005-07-05 | Genentech, Inc. | Compositions for microencapsulation of antigens for use as vaccines |
US5643605A (en) * | 1993-10-25 | 1997-07-01 | Genentech, Inc. | Methods and compositions for microencapsulation of adjuvants |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
US5997861A (en) * | 1994-10-31 | 1999-12-07 | Burstein Laboratories, Inc. | Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin |
ZA975889B (en) * | 1996-07-08 | 1998-02-23 | Genentech Inc | HIV envelope polypeptides and vaccine. |
US6585979B1 (en) | 1996-07-08 | 2003-07-01 | Genentech, Inc. | HIV envelope polypeptides and immunogenic composition |
US6271198B1 (en) | 1996-11-06 | 2001-08-07 | Genentech, Inc. | Constrained helical peptides and methods of making same |
US6121021A (en) | 1997-12-16 | 2000-09-19 | Connaught Laboratories Limited | Constitutive expression of non-infectious HIV-like particles |
US6289229B1 (en) * | 1998-01-20 | 2001-09-11 | Scimed Life Systems, Inc. | Readable probe array for in vivo use |
ES2299276T3 (es) | 1998-12-31 | 2008-05-16 | Novartis Vaccines And Diagnostics, Inc. | Polipeptidos env del vih modificados. |
JP2003523721A (ja) | 1998-12-31 | 2003-08-12 | カイロン コーポレイション | 抗原性hivc型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用 |
ES2303513T3 (es) | 1999-11-16 | 2008-08-16 | Geneart Ag | Genoma del intersubtipo (c/b') de vih-1 y sus aplicaciones. |
US7211659B2 (en) | 2001-07-05 | 2007-05-01 | Chiron Corporation | Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
US20030170614A1 (en) | 2001-08-31 | 2003-09-11 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
DE10255508A1 (de) * | 2002-11-27 | 2004-06-17 | Forschungszentrum Jülich GmbH | Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen |
US7658927B2 (en) * | 2003-05-12 | 2010-02-09 | University Of Florida Research Foundation, Inc. | Materials and methods for immunizing against FIV infection |
JP2006528244A (ja) | 2003-05-12 | 2006-12-14 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイティド | Fiv感染予防接種のための材料と方法 |
US20110150911A1 (en) * | 2003-11-19 | 2011-06-23 | Qui-Lim Choo | Methods and reagents for treating, preventing and diagnosing bunyavirus infection |
US20100285062A1 (en) | 2006-03-31 | 2010-11-11 | Novartis Ag | Combined mucosal and parenteral immunization against hiv |
US8512947B2 (en) | 2007-02-16 | 2013-08-20 | Drexel University | Detection of nucleic acids using a cantilever sensor |
US7892759B2 (en) * | 2007-02-16 | 2011-02-22 | Drexel University | Enhanced sensitivity of a cantilever sensor via specific bindings |
KR102071834B1 (ko) | 2009-10-26 | 2020-01-30 | 에프. 호프만-라 로슈 아게 | 글리코실화된 면역글로불린의 제조 방법 |
WO2011119920A2 (en) | 2010-03-25 | 2011-09-29 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
CN102552904A (zh) * | 2010-12-23 | 2012-07-11 | 徐州医学院附属医院 | 人类免疫缺陷病毒膜分子gp120功能域与人TGF-β1的重组分子 |
HUE037408T2 (hu) | 2011-06-10 | 2018-08-28 | Univ Oregon Health & Science | CMV glikoproteinek és rekombináns vektorok |
US20130189754A1 (en) | 2011-09-12 | 2013-07-25 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
EP2586461A1 (en) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Viral particles derived from an enveloped virus |
ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
EP2848937A1 (en) | 2013-09-05 | 2015-03-18 | International Aids Vaccine Initiative | Methods of identifying novel HIV-1 immunogens |
US10058604B2 (en) | 2013-10-07 | 2018-08-28 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
SG11202012043RA (en) | 2018-07-03 | 2021-01-28 | Gilead Sciences Inc | Antibodies that target hiv gp120 and methods of use |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4725669A (en) * | 1984-11-09 | 1988-02-16 | President And Fellows Of Harvard College | Assay for detecting infection by human T-cell lymphotropic virus-III |
AU600658B2 (en) * | 1984-12-24 | 1990-08-23 | Genentech Inc. | Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use |
US5166050A (en) * | 1986-08-20 | 1992-11-24 | Bristol-Myers Squibb Company | Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections |
IL89567A0 (en) * | 1988-03-28 | 1989-09-10 | Univ Leland Stanford Junior | Mutated hiv envelope protein |
EP0339504A3 (en) * | 1988-04-26 | 1990-09-12 | The Du Pont Merck Pharmaceutical Company | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals |
AU3775789A (en) * | 1988-06-10 | 1990-01-05 | Applied Biotechnology, Inc. | A method of evaluating recombinant vaccines against immunodeficiency virus |
US5116740A (en) * | 1988-08-16 | 1992-05-26 | Akzo N.V. | Method for producing native hiv gp160 |
AU6523590A (en) * | 1989-09-22 | 1991-04-18 | Idec Pharmaceuticals Corporation | Novel peptides associated with the cd4 binding region of gp120 and their methods of use |
DE69132795T3 (de) * | 1990-03-09 | 2008-07-10 | Novartis Vaccines and Diagnostics, Inc., Emeryville | Gereinigtes gp120, in dem seine natürliche konformation erhalten bleibt |
WO1993020104A1 (en) * | 1992-03-31 | 1993-10-14 | The Public Health Research Institute Of The City Of New York, Inc. | Monoclonal antibodies against a carbohydrate-dependent epitope related to the v2 region of hiv-1 gp120 |
-
1991
- 1991-04-01 JP JP50668391A patent/JP3494300B2/ja not_active Expired - Lifetime
- 1991-04-01 AT AT91907077T patent/ATE125157T1/de not_active IP Right Cessation
- 1991-04-01 DE DE69111440T patent/DE69111440T2/de not_active Revoked
- 1991-04-01 DK DK91907077.1T patent/DK0527760T3/da active
- 1991-04-01 WO PCT/US1991/002250 patent/WO1991015238A1/en active IP Right Grant
- 1991-04-01 EP EP91907077A patent/EP0527760B1/en not_active Revoked
- 1991-04-01 CA CA002078546A patent/CA2078546A1/en not_active Abandoned
- 1991-04-01 AU AU75847/91A patent/AU647108B2/en not_active Expired
- 1991-04-03 NZ NZ237666A patent/NZ237666A/xx unknown
-
1993
- 1993-11-09 AU AU50555/93A patent/AU5055593A/en not_active Abandoned
-
1994
- 1994-04-11 US US08/226,162 patent/US5674984A/en not_active Expired - Lifetime
-
1997
- 1997-02-19 US US08/802,361 patent/US5849533A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5674984A (en) | 1997-10-07 |
NZ237666A (en) | 1997-08-22 |
EP0527760B1 (en) | 1995-07-19 |
AU647108B2 (en) | 1994-03-17 |
ATE125157T1 (de) | 1995-08-15 |
AU7584791A (en) | 1991-10-30 |
EP0527760A1 (en) | 1993-02-24 |
JP3494300B2 (ja) | 2004-02-09 |
JPH05505611A (ja) | 1993-08-19 |
WO1991015238A1 (en) | 1991-10-17 |
AU5055593A (en) | 1994-01-27 |
US5849533A (en) | 1998-12-15 |
DE69111440T2 (de) | 1996-03-28 |
CA2078546A1 (en) | 1991-10-04 |
DE69111440D1 (de) | 1995-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0527760T3 (da) | Fremgangsmåder og præparater til vaccination mod HIV | |
ATE328068T1 (de) | Papillomavirus vakzine | |
DK614987A (da) | Syntetiske htlv-iii peptider, praeparater og anvendelser deraf | |
MX9203439A (es) | Una citocina mamifera, il-11 | |
ATE481480T1 (de) | Methoden und zusammensetzungen zur herstellung von polypeptiden | |
CY1107447T1 (el) | Ετερολογη εκφραση πρωτεϊνων των neisseria | |
DE69534778D1 (en) | Cathepsin-02-protease | |
DE3751506D1 (de) | Verbinden von polikristallinen Diamantformkörpern bei niedrigem Druck. | |
ES2129487T3 (es) | Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion. | |
NO912825L (no) | Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper. | |
IT8621106A0 (it) | Vettore ad espressione e secrezione in lieviti, utile per lapreparazione di proteine eterologhe. | |
NO852567L (no) | Thymopentinanaloger og fremgangsmmaate for deres fremstilling. | |
DK0771213T3 (da) | Haemophilus influenza adhærens- og penetrationsproteiner | |
DK0480949T4 (da) | Fremstilling af virusvaccine | |
DE69531235D1 (de) | Säugetier - Expressionssysteme für Hüllenprotingene des Hepatitit - C - Virus | |
ITRM920350A1 (it) | Epitopi immunologicamente omologhi di hla e proteine del virus hiv. | |
DE3854550D1 (de) | HIV-Peptide und Methoden für den Nachweis von HIV. | |
DE69634077D1 (de) | Haemophilus adhäsionsproteinen | |
DE69728897D1 (de) | Saeugetierchemokine | |
DE69736779D1 (de) | Zusammensetzungen von rekombinanten papillomavirus vakzinen | |
KR950700988A (ko) | 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof) | |
ATE294237T1 (de) | S?ugetier thymokingene | |
FI950248A0 (fi) | Rokotteita monisoluisia loisia vastaan | |
DK0815141T3 (da) | Antistof mod et fusionspolypeptid omfattende en histidinandel | |
DK8089D0 (da) | Monoclonale antistoffer, deres fremstilling og anvendelse. |